Evidence map›Paper›PMID 33931639›Full record

ArticleNature communications2021

Author Correction: Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation.

Nam-Shik Kim, Zhexing Wen, Jing Liu, Ying Zhou, Ziyuan Guo, Chongchong Xu, Yu-Ting Lin, Ki-Jun Yoon, Junhyun Park, Michelle Cho and 13 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Nam-Shik Kim *Department of Neuroscience and Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Zhexing Wen *Departments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurology, Emory University School of Medicine, Atlanta, GA, USA.ORCID http://orcid.org/0000-0002-1518-3845
Jing Liu *Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Ying ZhouInstitute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ziyuan GuoDepartment of Neuroscience and Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Chongchong XuDepartments of Psychiatry and Behavioral Sciences, Cell Biology, and Neurology, Emory University School of Medicine, Atlanta, GA, USA.
Yu-Ting LinInstitute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-1045-1871
Ki-Jun YoonDepartment of Neuroscience and Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Junhyun ParkInstitute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-1366-0238
Michelle ChoInstitute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Minji KimInstitute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-2339-4538
Xinyuan WangDepartment of Neuroscience and Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Huimei YuInstitute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Srilatha SakamuruNational Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD, USA.
Kimberly M ChristianDepartment of Neuroscience and Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kuei-Sen HsuDepartment of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.ORCID http://orcid.org/0000-0002-3498-5157
Menghang XiaNational Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Bethesda, MD, USA.
Weidong LiBio-X Institutes, Key Laboratory for the Genetics of Development and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Shanghai, China.
Christopher A RossDivision of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Russell L MargolisDivision of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Xin-Yun LuDepartment of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA. XYLU@augusta.edu.ORCID http://orcid.org/0000-0002-9103-4542
Hongjun SongDepartment of Neuroscience and Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA, USA. shongjun@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-8720-5310
Guo-Li MingDepartment of Neuroscience and Mahoney Institute for Neurosciences, Perelman School for Medicine, University of Pennsylvania, Philadelphia, PA, USA. gming@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-2517-6075

Funding

Functional roles of genetic risk factors for brain disorders in neurogenesis and neurodevelopmentR35NS097370 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI MING, GUO-LI · 2017 to 2024
$6.7M
Toxicology in the 21st Century Program (Tox21) - Systems ToxicologyZIATR000038 · NCATS · NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES · PI XIA, MENGHANG · 2015 to 2025
$5.7M
Loss-of-Function Analyses of SETD1A in Human Neural ModelsR01MH125528 · NIMH · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI MING, GUO-LI, PANG, ZHIPING P. · 2021 to 2025
$3.2M
Circuitry mechanisms underlying normal and aberrant adult hippocampal neurogenesisR01MH105128 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI MING, GUO-LI · 2014 to 2018
$2.0M
Sliced human neocortical organoids for modeling cortical laminar and columnar organization and functionRF1MH123979 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI MING, GUO-LI · 2020 to 2020
$1.7M
NIMH NIH HHS R01 MH105128NIMH NIH HHS R01 MH125528NIMH NIH HHS RF1 MH123979NINDS NIH HHS R35 NS097370
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33931639
PMCPMC8087755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.